EG+427+-+Main+logo+-+Full+color.png
EG 427 announces final Series A closing, achieving €18 million in total funds raised
13 juil. 2023 02h00 HE | EG 427
Paris, France, 13 July, 2023 – EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, announces today the final closing of a Series A financing. EG 427 raised an...